A simple explainer on the 340B drug pricing program, and why the Trump administration's new rebate plan has hospitals and ...
After years of bipartisan deliberation, U.S. Sen. Tim Kaine, D-Va., has introduced legislation to strengthen and protect a ...
The federal drug pricing program 340B helps hospitals and clinics in Virginia and across the nation care for underserved patients by requiring pharmaceutical companies to offer prescription discounts ...
The Health Resources and Services Administration’s (“HRSA”) August 3, 2026 “Notice Regarding 340B Rebate Model Pilot Program” sets the stage to address significant integrity concerns that have ...
Novo’s Wegovy pill thesis continues to bear out in 2026, as the oral obesity med keeps impressive sales apace while sparing ...
The 340B Drug Pricing Program may be partly driving U.S. hospital consolidation and worsening affordability for patients, some analysts have warned. Section 340B of the Public Health Service Act ...
Hello, everyone. Thank you for joining us, and welcome to the Cencora Inc. Q3 Fiscal Year 2026 Earnings Call. [Operator Instructions] I will now hand the conference over to Bennett Murphy. Bennett, ...
Earnings call Cencora delivered strong Q3 FY26 results with revenue up 5% to $84.8B and adjusted operating income up 17%, driven by specialty growth and the OneOncology acquisition. Adjusted EPS rose ...